Clinical Trials · NCT00002967

Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer

Name: Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Octreotide

Phase: Phase 3
Recruitment status: Completed
Sponsor: NSABP Foundation Inc
Enrollment: 0
Start date: May 1997
Locations: 108 sites, United States, Canada
Primary endpoint: Study in Breast Cancer

View Octreotide compound reference